Abstract
When I read Douglas Fleming's suggestion (Pharmaceutical Journal 2007; 279: 441) that Britain's pharmacists could “play an extended role in the management of seasonal influenza”, I reacted sceptically. Pharmaceutical chemists do tend to have exaggerated ideas of their own importance. Some years ago, the Royal Pharmaceutical Society tried to restrict the sale of over-the-counter nostrums to places within its own fiefdom. Aspirin, for example, should be banned from filling stations and be made available only through pharmacies with pharmacists “in attendance”. Much more recently, Alison White, Chief Executive of the National Pharmacy Association, was grumbling about her profession being excluded from Lord Darzi's review of the UK National Health Service (The Times, Oct 26, 2007).
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
